| Doggrell SA
Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity? [Journal Article]
Expert Opin Pharmacother 2005 Oct; 6(12):2141-4.
Full Citation | Publisher Full Text | Find Related Articles |
| Rimonabant, obesity and diabetes. [Journal Article]
Prescrire Int 2007 Jun; 16(89):122.
Abstract | Full Citation | Find Related Articles |
| Duh D, Vanddevijver A
[Rimonabant (Acomplia)] [Journal Article]
J Pharm Belg 2008 Mar; 63(1):27-8.
Full Citation | Find Related Articles |
| Boyd ST, Fremming BA
Update on rimonabant--a selective cannabinoid CB1 antagonist. [Letter]
Ann Pharmacother 2006 May; 40(5):994.
Full Citation | Publisher Full Text | Find Related Articles |
| Ducobu J, Sternon J
[Rimonabant (Acomplia), specific inhibitor of the endocannabinoid system] [Journal Article, Review]
J Pharm Belg 2005; 60(3):89-91.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Xie S, Furjanic MA, Ferrara JJ, et al.
The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB(1) receptor antagonism - or inverse agonism - as potential obesity treatment and other therapeutic use. [Journal Article]
J Clin Pharm Ther 2007 Jun; 32(3):209-31.
Abstract | Full Citation | Find Related Articles |
| Molecule of the month. Rimonabant hydrochloride. [Journal Article]
Drug News Perspect 2004 Jul-Aug; 17(6):403.
Full Citation | Publisher Full Text | Find Related Articles |
| Doggrell SA
Will the new CB1 cannabinoid receptor antagonist SR-147778 have advantages over rimonabant? [Journal Article, Review]
Expert Opin Investig Drugs 2005 Mar; 14(3):339-42.
Full Citation | Publisher Full Text | Find Related Articles |
| Bifulco M, Grimaldi C, Gazzerro P, et al.
Rimonabant: Just an Anti-obesity Drug? Current Evidence on Its Pleiotropic Effects. [JOURNAL ARTICLE]
Mol Pharmacol 2007 Feb 27.
Abstract | Full Citation | Find Related Articles |
  |
